Startup
Ochre Bio
Startup · Oxford, United Kingdom
Ochre Bio is an Oxford-based biotech startup combining computational genomics, machine learning, and RNA therapeutics to develop treatments for chronic liver diseases. Founded in 2019, the company uses human donor livers and large-scale transcriptomic data to identify novel drug targets, then designs RNA-based therapies to address conditions such as NASH and liver fibrosis. Ochre Bio has raised significant venture funding and works with transplant centers to validate its candidates in perfused human organs.
Connection map
Affiliation
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it